These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 32898709)

  • 1. Improved FcεRI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria.
    Oda Y; Fukunaga A; Washio K; Imamura S; Mizuno M; Hatakeyama M; Ogura K; Nishigori C
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1166-1176.e8. PubMed ID: 32898709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes.
    Johal KJ; Chichester KL; Oliver ET; Devine KC; Bieneman AP; Schroeder JT; MacGlashan DW; Saini SS
    J Allergy Clin Immunol; 2021 Jun; 147(6):2271-2280.e8. PubMed ID: 33713769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Responsiveness of Basophils via FcεRI Reflects Disease Activity in Chronic Spontaneous Urticaria.
    Oda Y; Fukunaga A; Washio K; Imamura S; Hatakeyama M; Ogura K; Nishigori C
    J Allergy Clin Immunol Pract; 2019; 7(8):2835-2844.e7. PubMed ID: 31136822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab.
    MacGlashan D; Saini S; Schroeder JT
    J Allergy Clin Immunol; 2021 Jun; 147(6):2295-2304.e12. PubMed ID: 33716077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of FcεRI-bearing leucocytes to omalizumab in chronic spontaneous urticaria.
    Alizadeh Aghdam M; Knol EF; van den Elzen M; den Hartog Jager C; van Os-Medendorp H; Knulst AC; Otten HG; Röckmann H
    Clin Exp Allergy; 2020 Mar; 50(3):364-371. PubMed ID: 31925825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basophil FcεRI Expression in Chronic Spontaneous Urticaria: A Potential Immunological Predictor of Response to Omalizumab Therapy.
    Deza G; Bertolín-Colilla M; Pujol RM; Curto-Barredo L; Soto D; García M; Hernández P; Gimeno R; Giménez-Arnau AM
    Acta Derm Venereol; 2017 Jun; 97(6):698-704. PubMed ID: 28303277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin.
    Metz M; Staubach P; Bauer A; Brehler R; Gericke J; Kangas M; Ashton-Chess J; Jarvis P; Georgiou P; Canvin J; Hillenbrand R; Erpenbeck VJ; Maurer M
    Theranostics; 2017; 7(5):1266-1276. PubMed ID: 28435464
    [No Abstract]   [Full Text] [Related]  

  • 8. Omalizumab may not inhibit mast cell and basophil activation in vitro.
    Gericke J; Ohanyan T; Church MK; Maurer M; Metz M
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1832-6. PubMed ID: 25257818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients.
    Jörg L; Pecaric-Petkovic T; Reichenbach S; Coslovsky M; Stalder O; Pichler W; Hausmann O
    Clin Exp Allergy; 2018 Feb; 48(2):196-204. PubMed ID: 29164723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of the Basophil High-Affinity IgE Receptor in Chronic Urticaria: Clinical Experience from a Tertiary Care Institution.
    Deza G; March-Rodríguez A; Sánchez S; Ribas-Llauradó C; Soto D; Pujol RM; Gimeno R; Giménez-Arnau AM
    J Allergy Clin Immunol Pract; 2019; 7(5):1619-1626.e1. PubMed ID: 30685572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between changes in the 7-day urticaria activity score after treatment with omalizumab and the responsiveness of basophils to FcεRI stimulation in patients with chronic spontaneous urticaria.
    Endo T; Toyoshima S; Hayama K; Tagui M; Niwa Y; Ito M; Terui T; Okayama Y
    Asia Pac Allergy; 2020 Apr; 10(2):e12. PubMed ID: 32411577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.
    Kaplan AP; Giménez-Arnau AM; Saini SS
    Allergy; 2017 Apr; 72(4):519-533. PubMed ID: 27861988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omalizumab response correlates with reduced IFN-γ-, IL-10- and IL-31-secreting cells in chronic spontaneous urticaria.
    Rauber MM; Pickert J; Holiangu L; Möbs C; Pfützner W
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):2078-2085. PubMed ID: 31954076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lin
    Ridge K; Moran B; Alvarado-Vazquez PA; Hallgren J; Little MA; Irvine AD; O'Farrelly C; Dunne J; Finlay CM; Conlon N
    Allergy; 2024 Sep; 79(9):2423-2434. PubMed ID: 38634175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgE receptor responsiveness of basophils in chronic inducible urticaria.
    Mizuno M; Oda Y; Imamura S; Washio K; Fukumoto T; Fukunaga A
    Front Immunol; 2022; 13():995596. PubMed ID: 36211415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atopy and Response to Omalizumab Treatment in Chronic Spontaneous Urticaria.
    Costa C; Esteves Caldeira L; Paulino M; Santos DF; Silva SL
    Int Arch Allergy Immunol; 2024; 185(3):260-266. PubMed ID: 38113870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher House Dust Mite-Specific IgE Levels among Chronic Spontaneous Urticaria Patients May Implicate Higher Basophil Reactivity.
    Liang G; Zhou J; Jiang L; Wang W; Wu Q; Gao C; Liu W; Li S; Feng S; Song Z
    Int Arch Allergy Immunol; 2023; 184(11):1126-1134. PubMed ID: 37604140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of Autologous Whole Blood Injection Efficacy in Patients with Chronic Spontaneous Urticaria with Autoreactivity: A Preliminary Study.
    Chen Q; Luo J; Yang X; Chen W; Liu W; Song Z
    Int Arch Allergy Immunol; 2024; 185(2):190-195. PubMed ID: 37952519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated steady status and distinctive FcεRI-mediated responsiveness in basophils of atopic dermatitis.
    Imamura S; Washio K; Mizuno M; Oda Y; Fukunaga A; Nishigori C
    Allergol Int; 2021 Jul; 70(3):327-334. PubMed ID: 33674191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In chronic spontaneous urticaria, increased Galectin-9 expression on basophils and eosinophils is linked to high disease activity, endotype-specific markers, and response to omalizumab treatment.
    Ji J; Tang M; Zhao Y; Zhang C; Shen Y; Zhou B; Liu C; Maurer M; Jiao Q
    Allergy; 2024 Sep; 79(9):2435-2447. PubMed ID: 39021347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.